{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:48:55Z","timestamp":1780926535360,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"National Institutes of Health Intramural Research Program","award":["ZIA AR041224"],"award-info":[{"award-number":["ZIA AR041224"]}]},{"name":"National Institutes of Health Medical Research Scholars Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s13555-025-01396-0","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:33:47Z","timestamp":1743827627000},"page":"1173-1179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of Superficial Fungal Infections in WHIM Syndrome"],"prefix":"10.1007","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct00128973","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jennifer","family":"Strong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutha","family":"Adhanom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshine","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine C.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hallaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Salancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi H.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Castelo-Soccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-9914","authenticated-orcid":false,"given":"Isaac","family":"Brownell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"1396_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng1149","volume":"34","author":"PA Hernandez","year":"2003","unstructured":"Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet. 2003;34:70\u20134.","journal-title":"Nat Genet"},{"key":"1396_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0002-9343(90)90187-I","volume":"89","author":"M Wetzler","year":"1990","unstructured":"Wetzler M, Talpaz M, Kleinerman ES, King A, Huh YO, Gutterman JU, et al. A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia. Am J Med. 1990;89:663\u201372.","journal-title":"Am J Med"},{"key":"1396_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1182\/blood.2023022658","volume":"144","author":"R Badolato","year":"2024","unstructured":"Badolato R, Alsina L, Azar A, Bertrand Y, Bolyard AA, Dale D, et al. A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome. Blood. 2024;144:35\u201345.","journal-title":"Blood"},{"key":"1396_CR4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI164918","author":"DH McDermott","year":"2023","unstructured":"McDermott DH, Velez D, Cho E, Cowen EW, DiGiovanna JJ, Pastrana DV, et al. A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI164918.","journal-title":"J Clin Invest"},{"key":"1396_CR5","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jaip.2019.01.045","volume":"7","author":"L Dotta","year":"2019","unstructured":"Dotta L, Notarangelo LD, Moratto D, Kumar R, Porta F, Soresina A, et al. Long-term outcome of WHIM syndrome in 18 patients: high risk of lung disease and HPV-related malignancies. J Allergy Clin Immunol Pract. 2019;7:1568\u201377.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1396_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/imr.12719","volume":"287","author":"DH McDermott","year":"2019","unstructured":"McDermott DH, Murphy PM. WHIM syndrome: immunopathogenesis, treatment and cure strategies. Immunol Rev. 2019;287:91\u2013102.","journal-title":"Immunol Rev"},{"key":"1396_CR7","doi-asserted-by":"crossref","unstructured":"Meltzer JC, Strong J, Martinez S, Salancy A, Adhanom R, Cowen EW et al. Recalcitrant Tinea Capitis in WHIM syndrome. Skin Health Dis. 2025;5(1):41\u20134.","DOI":"10.1093\/skinhd\/vzae002"},{"key":"1396_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","volume":"51","author":"B Havlickova","year":"2008","unstructured":"Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51:2\u201315.","journal-title":"Mycoses"},{"key":"1396_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1590\/abd1806-4841.20142569","volume":"89","author":"CAA Pires","year":"2014","unstructured":"Pires CAA, da Cruz NFS, Lobato AM, de Sousa PO, Carneiro FRO, Mendes AMD. Clinical, epidemiological, and therapeutic profile of dermatophytosis. An Bras Dermatol. 2014;89:259\u201364.","journal-title":"An Bras Dermatol"},{"key":"1396_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jdin.2020.10.003","volume":"2","author":"K Urban","year":"2021","unstructured":"Urban K, Chu S, Scheufele C, Giesey RL, Mehrmal S, Uppal P, et al. The global, regional, and national burden of fungal skin diseases in 195 countries and territories: a cross-sectional analysis from the Global Burden of Disease Study 2017. JAAD Int. 2021;2:22\u20137.","journal-title":"JAAD Int"},{"key":"1396_CR11","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1542\/pir.33.4.e22","volume":"33","author":"BP Kelly","year":"2012","unstructured":"Kelly BP. Superficial fungal infections. Pediatr Rev. 2012;33:e22-37.","journal-title":"Pediatr Rev"},{"key":"1396_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000495909","volume":"5","author":"A Alkeswani","year":"2019","unstructured":"Alkeswani A, Cantrell W, Elewski B. Treatment of tinea capitis. Skin Appendage Disord. 2019;5:201\u201310.","journal-title":"Skin Appendage Disord"},{"key":"1396_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jaad.2022.06.1201","volume":"88","author":"JAW Gold","year":"2023","unstructured":"Gold JAW, Wu K, Jackson BR, Benedict K. Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: analysis of commercial insurance claims data, United States. J Am Acad Dermatol. 2023;88:683\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1396_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/jof2010004","volume":"2","author":"C Rouzaud","year":"2015","unstructured":"Rouzaud C, Hay R, Chosidow O, Dupin N, Puel A, Lortholary O, et al. Severe dermatophytosis and acquired or innate immunodeficiency: a review. J Fungi Basel Switz. 2015;2(1):4.","journal-title":"J Fungi Basel Switz."},{"key":"1396_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/21678707.2017.1375403","volume":"5","author":"LE Heusinkveld","year":"2017","unstructured":"Heusinkveld LE, Yim E, Yang A, Azani AB, Liu Q, Gao J-L, et al. Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency. Expert Opin Orphan Drugs. 2017;5:813\u201325.","journal-title":"Expert Opin Orphan Drugs"},{"key":"1396_CR16","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1182\/blood.2020006675","volume":"137","author":"C Gallego","year":"2021","unstructured":"Gallego C, V\u00e9tillard M, Calmette J, Roriz M, Marin-Esteban V, Evrard M, et al. CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation. Blood. 2021;137:2770\u201384.","journal-title":"Blood"},{"key":"1396_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4103\/idoj.IDOJ_503_20","volume":"12","author":"K Sardana","year":"2021","unstructured":"Sardana K, Gupta A, Mathachan SR. Immunopathogenesis of dermatophytoses and factors leading to recalcitrant infections. Indian Dermatol Online J. 2021;12:389\u201399.","journal-title":"Indian Dermatol Online J"},{"key":"1396_CR18","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s10875-022-01312-7","volume":"42","author":"CB Geier","year":"2022","unstructured":"Geier CB, Ellison M, Cruz R, Pawar S, Leiss-Piller A, Zmajkovicova K, et al. Disease progression of WHIM syndrome in an international cohort of 66 pediatric and adult patients. J Clin Immunol. 2022;42:1748\u201365.","journal-title":"J Clin Immunol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01396-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01396-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01396-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T17:29:48Z","timestamp":1745688588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01396-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1396"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01396-0","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors Jennifer Strong, Rutha Adhanom, Caleb S. Kim, Yoshine Saito, Jasmine C. Meltzer, Patrick Hallaert, Sophia Martinez, Abigail Salancy, Heidi H. Kong, Edward W. Cowen, Leslie Castelo-Soccio, Philip M. Murphy, David H. McDermott, and Isaac Brownell have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"National Institutes of Health IRB approval (05-I-0213) and written informed consent was required for the natural history study (NCT00128973). No additional IRB approval or informed consent was required for patient data inclusion in this study. This study was performed in accordance with the Helsinki Declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}